Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Landgren

Showing results (131-140 of 519) with videos related to

Pageof 52
Sort By:
European Journal of Haematology|April 21, 2018
Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survivalIngemar Turesson, Magnus Bjorkholm, Cecilie Hveding Blimark, et al.
Blood Reviews|February 8, 2026
Bystander or perpetrator: Unravelling the significance and challenges of MGUSMalini Surapaneni, Jacob Edmisson, Attaya Suvannasankha, et al.
Acta Oncologica (Stockholm, Sweden)|July 13, 2004
Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphomaEva Osby, Johan Askling, Ola Landgren, et al.
Haematologica|November 2, 2020
Peripheral neuropathy and monoclonal gammopathy of undetermined significance: a population-based study including 15,351 cases and 58,619 matched controlsSæmundur Rögnvaldsson, Vilhjálmur Steingrímsson, Ingemar Turesson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Minimal residual disease: what are the minimum requirements?Mark Roschewski, Maryalice Stetler-Stevenson, Constance Yuan, et al.
Leukemia & Lymphoma|January 29, 2011
Concomitant and antecedent deep venous thrombosis and cancer survival in male US veteransLesley A Anderson, Steven C Moore, Gloria Gridley, et al.
Blood|January 11, 2007
BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?Kieron Dunleavy, R Eric Davis, Ola Landgren, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 30, 2006
Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut womenOla Landgren, Yawei Zhang, Sheila Hoar Zahm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2007
Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003Sigurdur Yngvi Kristinsson, Ola Landgren, Paul W Dickman, et al.
AIDS Research and Human Retroviruses|October 4, 2011
Increased levels of circulating cytokines with HIV-related immunosuppressionFatma M Shebl, Kai Yu, Ola Landgren, et al.
Pageof 52

Showing results (131-140 of 519) with videos related to

Sort By:
Pageof 52
European Journal of Haematology|April 21, 2018
Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survivalIngemar Turesson, Magnus Bjorkholm, Cecilie Hveding Blimark, et al.
Blood Reviews|February 8, 2026
Bystander or perpetrator: Unravelling the significance and challenges of MGUSMalini Surapaneni, Jacob Edmisson, Attaya Suvannasankha, et al.
Acta Oncologica (Stockholm, Sweden)|July 13, 2004
Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphomaEva Osby, Johan Askling, Ola Landgren, et al.
Haematologica|November 2, 2020
Peripheral neuropathy and monoclonal gammopathy of undetermined significance: a population-based study including 15,351 cases and 58,619 matched controlsSæmundur Rögnvaldsson, Vilhjálmur Steingrímsson, Ingemar Turesson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Minimal residual disease: what are the minimum requirements?Mark Roschewski, Maryalice Stetler-Stevenson, Constance Yuan, et al.
Leukemia & Lymphoma|January 29, 2011
Concomitant and antecedent deep venous thrombosis and cancer survival in male US veteransLesley A Anderson, Steven C Moore, Gloria Gridley, et al.
Blood|January 11, 2007
BCL-6 and rituximab in diffuse large B-cell lymphoma: where are we?Kieron Dunleavy, R Eric Davis, Ola Landgren, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 30, 2006
Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut womenOla Landgren, Yawei Zhang, Sheila Hoar Zahm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2007
Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003Sigurdur Yngvi Kristinsson, Ola Landgren, Paul W Dickman, et al.
AIDS Research and Human Retroviruses|October 4, 2011
Increased levels of circulating cytokines with HIV-related immunosuppressionFatma M Shebl, Kai Yu, Ola Landgren, et al.
Pageof 52